Interference of bone marrow CD56 + mesenchymal stromal cells in minimal residual disease investigation of neuroblastoma and other CD45 − /CD56 + pediatric malignancies using flow cytometry

Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma

(2019) Alexander Popov et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting

(2017) Julie R. Park et al.   JOURNAL OF CLINICAL ONCOLOGY

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

(2017) J Flores-Montero et al.   LEUKEMIA

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group

(2016) Susan A. Burchill et al.   CANCER

Expression of neural cell adhesion molecule and polysialic acid in human bone marrow-derived mesenchymal stromal cells

(2016) Maria S. Skog et al.   Stem Cell Research & Therapy

Comparative study of neural differentiation of bone marrow mesenchymal stem cells by different induction methods

(2015) M.W. Mu et al.   GENETICS AND MOLECULAR RESEARCH

Advances in Risk Classification and Treatment Strategies for Neuroblastoma

(2015) Navin R. Pinto et al.   JOURNAL OF CLINICAL ONCOLOGY

Neuroblastoma mRNAs Predict Outcome in Children With Stage 4 Neuroblastoma: A European HR-NBL1/SIOPEN Study

(2014) Virginie F. Viprey et al.   JOURNAL OF CLINICAL ONCOLOGY

Mesenchymal Stromal Cells Derived from the Bone Marrow of Acute Lymphoblastic Leukemia Patients Show Altered BMP4 Production: Correlations with the Course of Disease

(2014) Ángeles Vicente López et al.   PLoS One

Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children's Oncology Group

(2013) G. A. Yanik et al.   JOURNAL OF NUCLEAR MEDICINE

Cell-Surface Expression of Neuron-Glial Antigen 2 (NG2) and Melanoma Cell Adhesion Molecule (CD146) in Heterogeneous Cultures of Marrow-Derived Mesenchymal Stem Cells

(2013) Katie C. Russell et al.   TISSUE ENGINEERING PART A

Minimal Residual Disease is a Prognostic Marker for Neuroblastoma With Bone Marrow Infiltration

(2011) Jiao-Yang Cai et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Phenotypic Characterization of Distinct Human Bone Marrow-Derived MSC Subsets

(2009) Hans-Jörg Bühring et al.   Annals of the New York Academy of Sciences

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force

(2009) K Beiske et al.   BRITISH JOURNAL OF CANCER

Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification

(2009) Ilknur Kozanoglu et al.   CYTOTHERAPY

Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow

(2009) Steven G. DuBois et al.   PEDIATRIC BLOOD & CANCER

Immunophenotypic Expression by Flow Cytometric Analysis of Cocultured Skeletal Muscle and Bone Marrow Mesenchymal Stem Cells for Therapy Into Myocardium

(2008) K.A.T.C. Carvalho et al.   TRANSPLANTATION PROCEEDINGS